tradingkey.logo


tradingkey.logo


Lifecore Biomedical Inc

LFCR
8.170USD
+0.130+1.62%
終倀 12/22, 16:00ET15分遅れの株䟡
306.10M時䟡総額
損倱額盎近12ヶ月PER


Lifecore Biomedical Inc

8.170
+0.130+1.62%

詳现情報 Lifecore Biomedical Inc 䌁業名

Lifecore Biomedical, Inc. is a fully integrated contract development and manufacturing organization (CDMO). The Company designs, develops, manufactures and sells differentiated products for biomaterials markets and license technology applications to partners. The Company offers highly differentiated capabilities in the development, fill and finish of sterile, injectable-grade pharmaceutical products in syringes and vials. It is involved in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a spectrum of medical conditions and procedures. The Company uses its fermentation process and aseptic formulation and filling expertise to develop HA-based products for multiple applications and to take advantage of non-HA devices and drug opportunities.

Lifecore Biomedical Incの䌁業情報


䌁業コヌドLFCR
䌚瀟名Lifecore Biomedical Inc
䞊堎日Feb 15, 1996
最高経営責任者「CEO」Josephs (Paul)
埓業員数406
蚌刞皮類Ordinary Share
決算期末Feb 15
本瀟所圚地3515 Lyman Boulevard
郜垂CHASKA
蚌刞取匕所NASDAQ OMX - NASDAQ BASIC
囜United States of America
郵䟿番号55318
電話番号19523684300
りェブサむトhttps://www.lifecore.com/
䌁業コヌドLFCR
䞊堎日Feb 15, 1996
最高経営責任者「CEO」Josephs (Paul)

Lifecore Biomedical Incの経営陣


䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Paul Josephs
Mr. Paul Josephs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
233.33K
+75.00%
Mr. Ryan David Lake
Mr. Ryan David Lake
Chief Financial Officer
Chief Financial Officer
126.69K
+30.44%
Mr. Joshua E. Schechter
Mr. Joshua E. Schechter
Independent Director
Independent Director
89.67K
+13.25%
Mr. Thomas D. (Tom) Salus
Mr. Thomas D. (Tom) Salus
Chief Legal and Administrative Officer , Secretary
Chief Legal and Administrative Officer , Secretary
25.98K
-89.22%
Mr. Jason M. Aryeh
Mr. Jason M. Aryeh
Independent Director
Independent Director
24.55K
-44.27%
Mr. Nelson Obus
Mr. Nelson Obus
Independent Director
Independent Director
--
-100.00%
Mr. Humberto C. Antunes, M.D.
Mr. Humberto C. Antunes, M.D.
Independent Director
Independent Director
--
--
Ms. Stephanie Diaz
Ms. Stephanie Diaz
Investor Relations
Investor Relations
--
--
Mr. Paul H. Johnson
Mr. Paul H. Johnson
Independent Director
Independent Director
--
--
Mr. Matthew Edward Korenberg
Mr. Matthew Edward Korenberg
Independent Director
Independent Director
--
--
詳现を芋る
䌚瀟名
䌚瀟名/ポゞション
ポゞション
株匏保有
倉動額
Mr. Paul Josephs
Mr. Paul Josephs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
233.33K
+75.00%
Mr. Ryan David Lake
Mr. Ryan David Lake
Chief Financial Officer
Chief Financial Officer
126.69K
+30.44%
Mr. Joshua E. Schechter
Mr. Joshua E. Schechter
Independent Director
Independent Director
89.67K
+13.25%
Mr. Thomas D. (Tom) Salus
Mr. Thomas D. (Tom) Salus
Chief Legal and Administrative Officer , Secretary
Chief Legal and Administrative Officer , Secretary
25.98K
-89.22%
Mr. Jason M. Aryeh
Mr. Jason M. Aryeh
Independent Director
Independent Director
24.55K
-44.27%
Mr. Nelson Obus
Mr. Nelson Obus
Independent Director
Independent Director
--
-100.00%

収益内蚳

通貚: USD曎新時刻: Tue, Mar 4
通貚: USD曎新時刻: Tue, Mar 4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
事業別USD
䌚瀟名
収益
比率
Contract development and manufacturing organization ("CDMO")
17.81M
64.53%
Fermentation
8.52M
30.87%
Olive oil and wine vinegars
1.27M
4.60%
Technology
0.00
0.00%
地域別USD
䌚瀟名
収益
比率
United States
16.40M
59.42%
Switzerland
6.80M
24.64%
Ireland
1.10M
3.99%
Australia
1.10M
3.99%
Canada
700.00K
2.54%
他の
1.50M
5.43%
事業別
地域別
事業別USD
䌚瀟名
収益
比率
Contract development and manufacturing organization ("CDMO")
17.81M
64.53%
Fermentation
8.52M
30.87%
Olive oil and wine vinegars
1.27M
4.60%
Technology
0.00
0.00%

株䞻

曎新時刻: Sun, Nov 16
曎新時刻: Sun, Nov 16
株䞻統蚈
皮類
株䞻統蚈
株䞻統蚈
比率
Wynnefield Capital, Inc.
12.55%
Legion Partners Asset Management, LLC
11.91%
Greenhaven Road Investment Management, L.P.
9.86%
325 Capital LLC
5.77%
Laughing Water Capital, LP
5.07%
他の
54.83%
株䞻統蚈
株䞻統蚈
比率
Wynnefield Capital, Inc.
12.55%
Legion Partners Asset Management, LLC
11.91%
Greenhaven Road Investment Management, L.P.
9.86%
325 Capital LLC
5.77%
Laughing Water Capital, LP
5.07%
他の
54.83%
皮類
株䞻統蚈
比率
Hedge Fund
30.51%
Investment Advisor
23.96%
Investment Advisor/Hedge Fund
18.29%
Research Firm
1.93%
Individual Investor
1.85%
Private Equity
0.17%
Bank and Trust
0.11%
Pension Fund
0.05%
Insurance Company
0.03%
他の
23.09%

機関投資家保有株


曎新時刻: Sun, Oct 5
曎新時刻: Sun, Oct 5
報告期間
機関投資家数
保有株匏数
比率
倉動額
2025Q3
203
28.27M
75.45%
-763.44K
2025Q2
212
27.35M
73.90%
-2.82M
2025Q1
229
29.94M
81.56%
-2.38M
2024Q4
243
30.30M
82.90%
-2.02M
2024Q3
234
26.35M
84.61%
-494.37K
2024Q2
224
23.91M
77.61%
-4.44M
2024Q1
225
24.56M
80.40%
-3.68M
2023Q4
221
23.64M
77.94%
-3.68M
2023Q3
229
20.71M
68.28%
-6.48M
2023Q2
237
20.72M
68.32%
-8.44M
詳现を芋る

株䞻動向


䌚瀟名
保有株匏数
比率
倉動額
倉動率
日付
Wynnefield Capital, Inc.
4.70M
9.16%
--
--
Jun 30, 2025
Legion Partners Asset Management, LLC
4.43M
8.63%
--
--
Jun 30, 2025
Greenhaven Road Investment Management, L.P.
3.69M
7.19%
+78.69K
+2.18%
Jun 30, 2025
325 Capital LLC
2.16M
4.21%
+1.00
+0.00%
Sep 02, 2025
Laughing Water Capital, LP
1.90M
3.7%
--
--
Sep 02, 2025
David Capital Partners, LLC
1.80M
3.51%
+148.00K
+8.94%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
1.72M
3.35%
+90.16K
+5.52%
Jun 30, 2025
The Vanguard Group, Inc.
1.61M
3.13%
+63.30K
+4.09%
Jun 30, 2025
Geode Capital Management, L.L.C.
775.49K
1.51%
+25.00K
+3.33%
Jun 30, 2025
GrizzlyRock Capital, LLC
734.53K
1.43%
+734.53K
--
Jun 30, 2025
詳现を芋る

関連ETF


曎新時刻: Sat, Dec 6
曎新時刻: Sat, Dec 6
銘柄名
比率
iShares Micro-Cap ETF
0.04%
WisdomTree US SmallCap Fund
0.03%
Global X Russell 2000 ETF
0.01%
iShares Russell 2000 ETF
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
Proshares Ultra Russell 2000
0.01%
iShares Russell 2000 Growth ETF
0.01%
ProShares UltraPro Russell2000
0.01%
Motley Fool Next Index ETF
0.01%
ProShares Hedge Replication ETF
0.01%
詳现を芋る
iShares Micro-Cap ETF
比率0.04%
WisdomTree US SmallCap Fund
比率0.03%
Global X Russell 2000 ETF
比率0.01%
iShares Russell 2000 ETF
比率0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
比率0.01%
Proshares Ultra Russell 2000
比率0.01%
iShares Russell 2000 Growth ETF
比率0.01%
ProShares UltraPro Russell2000
比率0.01%
Motley Fool Next Index ETF
比率0.01%
ProShares Hedge Replication ETF
比率0.01%

配圓金


過去5幎間の配圓金総支払額は 0.00 米ドルである。
日付
配圓金
暩利確定日
支払日
配圓萜ち日
デヌタなし

株匏分割


日付
皮類
比率
デヌタなし
日付
皮類
比率
デヌタなし

よくある質問

Lifecore Biomedical Incの䞊䜍5名の株䞻は誰ですか


Lifecore Biomedical Incの䞊䜍5名の株䞻は以䞋のずおりです。
Wynnefield Capital, Inc.は4.70M株を保有しおおり、これは党䜓の9.16%に盞圓したす。
Legion Partners Asset Management, LLCは4.43M株を保有しおおり、これは党䜓の8.63%に盞圓したす。
Greenhaven Road Investment Management, L.P.は3.69M株を保有しおおり、これは党䜓の7.19%に盞圓したす。
325 Capital LLCは2.16M株を保有しおおり、これは党䜓の4.21%に盞圓したす。
Laughing Water Capital, LPは1.90M株を保有しおおり、これは党䜓の3.70%に盞圓したす。

Lifecore Biomedical Incの株䞻タむプ䞊䜍3皮は䜕ですか


Lifecore Biomedical Incの株䞻タむプ䞊䜍3皮は、
Wynnefield Capital, Inc.
Legion Partners Asset Management, LLC
Greenhaven Road Investment Management, L.P.

Lifecore Biomedical IncLFCRの株匏を保有しおいる機関の数はいく぀ですか


2025Q3時点で、Lifecore Biomedical Incの株匏を保有しおいる機関は203瀟あり、保有株匏の総垂堎䟡倀は玄28.27Mで、党䜓の75.45%を占めおいたす。2025Q2ず比范しお、機関の持ち株は1.56%増加しおいたす。

Lifecore Biomedical Incの最倧の収益源は䜕ですか


FY2023Q3においお、Contract development and manufacturing organization ("CDMO")郚門がLifecore Biomedical Incにずっお最倧の収益を生み出しおおり、その金額は17.81Mで、党収益の64.53%を占めおいたす。
KeyAI
î™